Cited by 163Advanced Glycation End Products researchChronic Kidney Disease and DiabetesRenal Diseases and Glomerulopathies

The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.

Advanced glycation end products mediated cellular and molecular events in the pathology of diabetic nephropathy

Open access

Kumar Pasupulati, Anil, Chitra, P. Swathi, Reddy, G. Bhanuprakash·2016·Biomolecular Concepts

DOI 10.1515/bmc-2016-0021

Open this paper in CoChat — free account

Abstract

Diabetic nephropathy (DN) is a major cause of morbidity and mortality in diabetic patients and a leading cause of end-stage renal disease (ESRD). Degenerative changes such as glomerular hypertrophy, hyperfiltration, widening of basement membranes, tubulointerstitial fibrosis, glomerulosclerosis and podocytopathy manifest in various degrees of proteinuria in DN. One of the key mechanisms implicated in the pathogenesis of DN is non-enzymatic glycation (NEG). NEG is the irreversible attachment of reducing sugars onto free amino groups of proteins by a series of events, which include the formation of Schiff’s base and an Amadori product to yield advanced glycation end products (AGEs). AGE modification of client proteins from the extracellular matrix induces crosslinking, which is often associated with thickening of the basement membrane. AGEs activate several intracellular signaling cascades upon interaction with receptor for AGEs (RAGE), which manifest in aberrant cellular responses such as inflammation, apoptosis and autophagy, whereas other receptors such as AGE-R1, AGE-R3 and scavenger receptors also bind to AGEs and ensue endocytosis and degradation of AGEs. Elevated levels of both serum and tissue AGEs are associated with adverse renal outcome. Increased evidence supports that attenuation of AGE formation and/or inhibition of RAGE activation manifest(s) in improving renal function. This review provides insights of NEG, discusses the cellular and molecular events triggered by AGEs, which manifest in the pathogenesis of DN including renal fibrosis, podocyte epithelial-mesenchymal transition and activation of renin-angiotensin system. Therapies designed to target AGEs, such as inhibitors of AGEs formation and crosslink breakers, are discussed.

Integrity signals

Registry

Crossref · 10.1515/bmc-2016-0021

Cites

110 of 110 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Advanced Glycation End Products: Sparking the Development of Diabetic Vascular Injury
Goldin, A., Beckman, J. A., Schmidt, A. M., & Creager, M. A. (2006) · Circulation · doi:10.1161/circulationaha.106.621854 · Cited by 2,261
Dehydrated Foods, Chemistry of Browning Reactions in Model Systems
Hodge, J. E. (1953) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf60015a004 · Cited by 1,979
Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins.
Neeper, M. P., Schmidt, A. M., Brett, J., Yan, S. D., Wang, F., Pan, Y., Elliston, K. O., Stern, D., & SHAW, A. R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42138-2 · Cited by 1,545
Understanding RAGE, the receptor for advanced glycation end products
Bierhaus, A., Humpert, P. M., Morcos, M., Wendt, T., Chavakis, T., Arnold, B., Stern, D. M., & Nawroth, P. P. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0688-7 · Cited by 1,297
Advanced glycation end products in foods and a practical guide to their reduction in the diet
Uribarri, J., Woodruff, S., Goodman, S., Cai, W., Chen, X., Pyzik, R., Yong, A., Striker, G. E., & Vlassara, H. (2010) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2010.03.018 · Cited by 1,289
Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose
Thornalley, P. J., LANGBORG, A., & Minhas, H. S. (1999) · Biochemical Journal · doi:10.1042/bj3440109 · Cited by 1,209
Role of advanced glycation end products in cellular signaling
Ott, C., Jacobs, K., Haucke, E., Navarrete Santos, A., Grune, T., & Simm, A. (2014) · Redox Biology · doi:10.1016/j.redox.2013.12.016 · Cited by 1,150
Aminoguanidine Prevents Diabetes-Induced Arterial Wall Protein Cross-Linking
Brownlee, M., Vlassara, H., Kooney, A., Ulrich, P. C., & Cerami, A. (1986) · Science · doi:10.1126/science.3487117 · Cited by 1,146
Identification of N epsilon-carboxymethyllysine as a degradation product of fructoselysine in glycated protein.
Ahmed, M. U., Thorpe, S. R., & Baynes, J. W. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)89188-3 · Cited by 864
Nonenzymatic Browning in Vivo: Possible Process for Aging of Long-Lived Proteins
Monnier, V. M., & Cerami, A. (1981) · Science · doi:10.1126/science.6779377 · Cited by 773

Show all 110 references

Research works printed but not linked: 1

Alam S, Ahsan A, Alam S. Newer insights in drugs inhibiting formation and accumulation of advanced glycation end products. J Biochem Tech 2013; 5: 666–72.

Sorted by citations

Items 101–163 of 163

Role of Semaphorin 3A in Kidney Development and Diseases
Sang, Y., Tsuji, K., Nakanoh, H., Fukushima, K., Kitamura, S., & Wada, J. (2023) · Diagnostics · doi:10.3390/diagnostics13193038 · Cited by 6
L-Theanine Extends the Lifespan of Caenorhabditis elegans by Reducing the End Products of Advanced Glycosylation
Huang, Z., Jing, H., Pan, Y., Cai, H., Zhang, W., Zhu, J., Zhang, N., Wu, D., Xu, W., Qiu, H., et al. (2025) · Foods · doi:10.3390/foods14020221 · Cited by 7
Advanced Glycation End Products and Diabetes
Hadzi‐Petrushev, N., Angelovski, M., & Mladenov, M. I. (2023) · Contemporary Endocrinology · doi:10.1007/978-3-031-39721-9_5 · Cited by 7
Non-enzymatic glycation and diabetic kidney disease
Pasupulati, A. K., Nagati, V., Paturi, A. S. V., & Reddy, G. B. (2024) · Vitamins and hormones · doi:10.1016/bs.vh.2024.01.002 · Cited by 6
Self-citation
Effects of transforming growth factor beta-activated kinase 1 (TAK1) on apoptosis of HK-2 cells in the high glucose environment
Wang, Y., Zhao, L., Qiu, D., Shi, Y., & Duan, H. (2022) · Bioengineered · doi:10.1080/21655979.2022.2040875 · Cited by 6
Decoding the role of aldosterone in glycation-induced diabetic complications
Apte, M. M., Zambre, S., Pisar, P., Roy, B., & Tupe, R. S. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150107 · Cited by 6
Benfotiamine reduced collagen IV contents of sciatic nerve in hyperglycemic rats
Ghasemi, L. V., Rassouli, M. B., Matin, M. M., & Mahdavi-Shahri, N. (2021) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-020-00666-2 · Cited by 6
Exploratory Metabolomic Analysis Based on Reversed-Phase Liquid Chromatography–Mass Spectrometry to Study an In Vitro Model of Hypoxia-Induced Metabolic Alterations in HK-2 Cells
Bernardo‐Bermejo, S., Sánchez‐López, E., Tan, L., Martínez, S. B., Jiang, Z., Castro‐Puyana, M., Lucio-Cazaña, F. J., & Marina, M. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147399 · Cited by 6
Functional food prevents diabetic nephropathy in a rat model through inhibition of aldose reductase and accumulation of advanced glycation end-products
Kalahasti, K. K., Nagaraju, M., Jakhotia, S., Reddy, G. B., & Reddy, G. B. (2025) · PharmaNutrition · doi:10.1016/j.phanu.2025.100446 · Cited by 5
Self-citation
Strategies to address diabetic kidney disease burden in Mexico: a narrative review by the Mexican College of Nephrologists
Palomo‐Piñón, S., Aguilar-Alonso, J. A., Chavez-Iñiguez, J. S., Hernández-Arellanes, F. E., Mariano-Murga, J. A., Flores-Rodríguez, J. C., Pérez-López, M. J., Pérez, F. P., Treviño–Becerra, A., Guillén-Graf, A. E., et al. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1376115 · Cited by 5
Molecular mechanisms of Potentilla Discolor Bunge in regulating ferroptosis to alleviate DKD via the Nrf2 signaling pathway
Liu, Y., Cai, Y., Wei, X., Gao, K., Jin, G., Zhou, X., & Zhao, Z. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120035 · Cited by 6
Cardiac Troponin T: The Impact of Posttranslational Modifications on Analytical Immunoreactivity in Blood up to the Excretion in Urine
de Boer, D., Streng, A. S., van Doorn, W. P. T. M., Vroemen, W. H. M., Bekers, O., Wodzig, W. K. W. H., & Mingels, A. M. A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-63908-2_4 · Cited by 5
Investigation of the α-Dicarbonyl Compounds in Some Snack Foods by HPLC Using Precolumn Derivatization with 4-Nitro-1,2-Phenylenediamine
(2021) · Biointerface Research in Applied Chemistry · doi:10.33263/briac122.22422250 · Cited by 5
Administration of sodium hydrosulfide reduces remote organ injury by an anti-oxidant mechanism in a rat model of varicocele.
Lorian, K., Kadkhodaee, M., Kianian, F., Abdi, A., & Seifi, B. (2020) · PubMed Central · doi:10.22038/ijbms.2019.39727.9412 · Cited by 5
Biomarkers in Diabetic Kidney Disease: Early Detection, Prognostic Assessment, and Integration with Multi-Omics Signatures
Rroji, M., Bob, F. R., Cicero, L. L., Figurek, A., & Spasovski, G. (2026) · Life · doi:10.3390/life16071164 · Cited by 4
An Updated Review on Diabetic Nephropathy: Potential Mechanisms, Biomarkers, Therapeutic Targets and Interventional Therapies
Nadendla, R. R., Khairunnisa, K., Aziz, N., Pyne, C., Panigrahy, U. P., Wal, P., Kulkarni, M. H., & Rasheed, A. (2024) · Current Diabetes Reviews · doi:10.2174/0115733998291920240611063402 · Cited by 4
Prevalence of microvascular complications and associated factors among diabetes mellitus patients in Ethiopia: Systematic review and meta-analysis
Kumie, G., Nigatie, M., Alamrew, A., Gedfie, S., Kassahun, W., Jemal, A., Mulugeta, C., Ayana, S., Ayele, M., Lake, E. S., et al. (2024) · Microvascular Research · doi:10.1016/j.mvr.2024.104779 · Cited by 4
Unveiling VCAM‐1’s Multifaceted Role in Secondary Diabetic Complications
Kaur, P., Ritu, Sharma, K., Goyal, R. K., Basist, P., Khan, R., & Alhalmi, A. (2025) · Journal of Food Quality · doi:10.1155/jfq/9206712 · Cited by 4
Microvascular Complications Associated with Advanced Glycation End Products in Diabetes
Reddy, N. V. L. S., V, Raju, M. G., Papani, J., & Edunoori, K. (2023) · Asian Journal of Research in Biochemistry · doi:10.9734/ajrb/2023/v13i3262 · Cited by 5
Genetic polymorphism of glyoxalase I gene (A419C and C-7 T) and nephropathy risk in patients with type 2 diabetes mellitus among north Indian population: A case-control study
Maithilikarpagaselvi, N., Kanwar, T., Rathore, M., Sreenivasulu, K., Bajpai, N. K., & Banerjee, M. (2024) · Human Gene · doi:10.1016/j.humgen.2024.201322 · Cited by 4
Novel indicator of microvascular complications in patients with type 2 diabetes mellitus and shortened erythrocyte lifespan: a multicenter cross-sectional analysis
Wu, Y., Zhang, B., Ma, X., Yu, P., Zhou, S., & Wang, X. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01591-1 · Cited by 5
Zafirlukast, a Cysteinyl Leukotriene Receptor 1 Antagonist, Reduces the Effect of Advanced Glycation End-Products in Rat Renal Mesangial Cells In Vitro
Yan, L., Sun, A., & Xu, X. (2019) · Medical Science Monitor · doi:10.12659/msm.918187 · Cited by 4
İleri Glikasyon Son Ürünlerinin Diyabet Komplikasyonları Üzerine Etkileri: Bir Derleme
Demirer, B., & Yardımcı, H. (2022) · Journal of Nutrition and Dietetics · doi:10.33076/2022.bdd.1516 · Cited by 4
RAGE/SNAIL1 signaling drives epithelial-mesenchymal plasticity in metastatic triple-negative breast cancer
Pujals, M., Mayans, C., Bellio, C., Méndez, O., Greco, E., Fasani, R., Alemany‐Chavarria, M., Zamora, E., Padilla, L., Mitjans, F., et al. (2023) · Oncogene · doi:10.1038/s41388-023-02778-4 · Cited by 4
The association of RAGE gene polymorphisms with inflammatory and oxidative stress markers in diabetic kidney disease patients
Kamel, W. A., Haghi, M., Khosroshahi, H. T., & Dehghan, G. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10846-z · Cited by 3
Association between skin autofluorescence and all-cause mortality, cardiovascular mortality and cardiovascular disease: a systematic review and meta-analysis
Pascual‐Morena, C., Lucerón‐Lucas‐Torres, M., Martínez‐García, I., Rodríguez‐Gutiérrez, E., Reynolds-Cortez, V., & Patiño‐Cardona, S. (2025) · Clinical Research in Cardiology · doi:10.1007/s00392-025-02818-x · Cited by 4
Taurine attenuates diabetic nephropathy by suppressing the HMGB1/TLR4/MyD88/NF-κB axis in mice
Lin, S., Rao, Y., Wang, X., Song, Y., He, M., Yang, Y., Qi, Z., Wang, Y., Fan, X., Wu, Y., et al. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116525 · Cited by 3
Mechanism of metabolic memory: progression in diabetic nephropathy—a descriptive review
Begum, F., & Lakshmanan, K. (2024) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-024-00595-2 · Cited by 3
On the Prediction of In Vitro Arginine Glycation of Short Peptides Using Artificial Neural Networks
Que-Salinas, U., Martinez-Peón, D., Reyes-Figueroa, A. D., Ibarra, I., & Scheckhuber, C. Q. (2022) · Sensors · doi:10.3390/s22145237 · Cited by 4
Diabetic nephropathy patients show hyper-responsiveness to N6-carboxymethyllysine
Dias, C. G., Venkataswamy, L., & Balakrishna, S. (2022) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x2022e11984 · Cited by 3
Role of advanced glycation end products in the onset of diabetic kidney disease complications
de Paula, M. L. A., Villela, A. M. R., Negri, M., Kanaan, S., & Cardoso-Weide, L. C. (2017) · Clinical & Biomedical Research · doi:10.4322/2357-9730.74457 · Cited by 4
Shenkang recipe alleviates renal aging in diabetic kidney disease by interfering with the lysine-specific demethylase KDM6B to modulate the PPAR-γ signaling pathway
Zuo, A., Xie, J., Shao, J., Li, S., Lin, H., Wang, S., Sun, W., Xia, J., Jiang, W., Sun, J. M., et al. (2023) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2023.100216 · Cited by 3
PATHOGENETIC ROLE OF TRANSFORMING GROWTH FACTOR BETA (TGF-β) IN THE MECHANISMS OF DEVELOPMENT OF DIABETIC NEPHROPATHY (literature review)
Nahornyi, О. V., & Ziablitsev, S. V. (2025) · Medical Science of Ukraine (MSU) · doi:10.32345/2664-4738.1.2025.16 · Cited by 2
Alpha-lipoic acid suppressesNε-(carboxymethyl) lysine-induced epithelial mesenchymal transition in HK-2 human renal proximal tubule cells
Lo, M., Chen, M., Hsueh, Y.-T., Kuo, H.-T., & Lee, H.-M. (2018) · Free Radical Research · doi:10.1080/10715762.2018.1489129 · Cited by 2
Assessing the Impact of Aldose Reductase (ALR2) Regulatory Gene Polymorphism in Diabetic Retinopathy Patients
Musa, H. R., Musa, A. R., Muhammed, Y. G., Batagarawa, U. S., & Ibrahim, A. (2024) · BioMed Target Journal · doi:10.59786/bmtj.223 · Cited by 2
The influence of toxic advanced glycation end-products (TAGEs) on the development of diabetic nephropathy
Simkova, P., & Capcarová, M. (2024) · Archives of Ecotoxicology · doi:10.36547/ae.2024.6.1.13-16 · Cited by 2
Vascular actions of Ang 1–7 and Ang 1–8 through EDRFs and EDHFs in non-diabetes and diabetes mellitus
Mahmood, N. M. S., Mahmud, A. M. R., & Maulood, I. M. (2025) · Nitric Oxide · doi:10.1016/j.niox.2025.02.003 · Cited by 3
Endocrine Considerations in Pregnant Women with Chronic Kidney Disease
Presswala, L. S., & Myers, A. K. (2019) · Springer eBooks · doi:10.1007/978-3-030-25324-0_10 · Cited by 1
Glucose variability in subjects with type 1 diabetes: the relationships with non-enzymatic glycation, albuminuria and renal function
Klimontov, V. V., Semenova, J. F., & Vigel, A. K. (2020) · IEEE Ural-Siberian Conference on Computational Technologies in Cognitive Science, Genomics and Biomedicine (CSGB) · doi:10.1109/csgb51356.2020.9214670 · Cited by 1
The Implications of Fruit and Vegetable Consumption in Patients with Diabetes
Meier, M., Greenspan, P., Keedy, C. A., & Misher, A. (2021) · Journal of Pharmacy and Nutrition Sciences · doi:10.29169/1927-5951.2021.11.04 · Cited by 1
Senna occidentalis Leaf Extracts Ameliorate Biochemical Parameters of Diabetic Nephropathy in Diabetic Wistar Rats
Ibrahim, R., Alabi, M. A., Yusuf, B. O., Ibrahim, L. B., Ahmad, J., Ogunyale, K., Oladiji, E. O., & Bashir, R. (2022) · Journal of Medical Sciences(Faisalabad) · doi:10.3923/jms.2022.208.218 · Cited by 1
Addressing the Problem of Lysine Glycation Prediction in Proteins via Recurrent Neural Networks
Que-Salinas, U., Martinez-Peón, D., Méndez, G. M., Argüelles-Lucho, P., Reyes-Figueroa, A. D., & Scheckhuber, C. Q. (2025) · BioMed Research International · doi:10.1155/bmri/2426944 · Cited by 1
Impact of diabetes on cellular connections: Pathological insights and emerging therapeutic targets
Kanwal, A., Kanwar, N., Shetty, M. P., Rana, K., Alisi, A., Bhatia, A., & Bharati, S. (2025) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2025.103300 · Cited by 1
Stop the “Vicious Cycle” induced by Glycative Stress.
Yonei, Y., Yagi, M., & Takabe, W. (2020) · doi:10.24659/gsr.7.1_13 · Cited by 1
Advanced Glycation End Products and Malondialdehyde Serum Level Association with Nephropathy in Type Two Diabetic Patients
Hassan, A. A., Zbaar, S. A., & Khedhair, K. A. (2021) · Indian Journal of Forensic Medicine & Toxicology · doi:10.37506/ijfmt.v15i4.17257 · Cited by 1
Structure-activity relationship in advanced glycation end products formation inhibitory activity of phlorotannins
Sekiguchi, M., Shinoda, S., Uno, A., Masaki, T., Sasaki, T., & Ishiyama, H. (2022) · Bioscience Biotechnology and Biochemistry · doi:10.1093/bbb/zbac106 · Cited by 1
Diabetic Kidney Disease: Goals for Management, Prevention, and Awareness
Greco, C. W., & Hall, J. M. (2023) · Encyclopedia · doi:10.3390/encyclopedia3030083 · Cited by 2
Metabolic Adaptations in Diabetes Mellitus and Cancer
Pasupulati, A. K., Dunna, N. R., & Talluri, S. (2019) · Springer eBooks · doi:10.1007/978-981-32-9393-9_4
Advanced glycation end-products associate with podocytopathy in type II diabetic patientsPreprint
Nishad, R., Tahaseen, S. V., Motrapu, M., Kavvuri, R., Kodali, K., & Pasupulati, A. K. (2021) · Research Square · doi:10.21203/rs.3.rs-192615/v1
Empagliflozin Alleviates Diabetic Renal Tubular Lipid Accumulation and NLRP3 Inflammasome Activation Through AGEs-RAGE PathwayPreprint
Liu, Z., Chen, J., Sun, L., Li, J., & Sun, H. Q. (2021) · Research Square · doi:10.21203/rs.3.rs-870754/v1
Analysis of Shenhuang Capsule using HPLC: Method Development, Validation, and Application
Si, Y., Huang, Y., Chen, M., Wu, Z., Li, G., Li, H., Ge, P., Liu, H., Zhang, W., & Yan-li, X. (2022) · Current Pharmaceutical Analysis · doi:10.2174/1573412918666220427135241
İleri Glikasyon Son Ürünleri (AGE) ve Polikistik Over Sendromu İlişkisi
AŞIK, B. N., & ÇİNTESUN, E. E. (2023) · İstanbul Sabahattin Zaim Üniversitesi Fen Bilimleri Enstitüsü Dergisi · doi:10.47769/izufbed.1318435 · Cited by 1
Pathogenic Role and Preventive Strategy of Advanced Glycation End Products in Diabetic Kidney Disease
李, 燕. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.13102220
Flavonoids from Coreopsis tinctoria Nutt alleviate renal injuries in db/db mice models through the AGE/RAGE pathway
Guo, L., Meng, Y., Zhang, H., Li, S., & Zhang, W. (2025) · Noordanesh. · doi:10.61186/ijkd.9113
Advanced glycation end products and human diseases
Zahra, H. A. (2025) · Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale · doi:10.4081/jbr.2025.12656
Uncovering the possible link between dietary advanced glycation end products and mortality risk: A systematic review and meta-analysis
Ahmadirad, H., Farhadnejad, H., Norouzzadeh, M., Jahromi, M. K., Mokhtari, E., Omrani, M., Teymoori, F., Sadeghi, R., Mirmiran, P., & Bagherian, M. (2025) · Cancer Epidemiology · doi:10.1016/j.canep.2025.102807
Effect comparison of inulin with different molecular weights ameliorating intracerebral neuroinflammation induced by advanced glycation end products (AGEs) in diabetic mice
Li, Y., Zong, A., Xu, C., Liu, L., Zhang, Y., Li, B., Du, F., & Xu, T. (2025) · Food & Function · doi:10.1039/d5fo00867k
The Effects of Thiosemicarbazone-based Oxovanadium (IV) Complex on the Lens and Skin Tissues in Streptozotocin-Induced Diabetic Rats and Computational Studies for the Key Target Proteins of the Lens Tissues
Yanardağ, R., Ertik, O., Bal‐Demirci, T., Ülküseven, B., & Tunalı, S. (2025) · Journal of the Turkish Chemical Society Section A Chemistry · doi:10.18596/jotcsa.1734840
Gene regulatory networks involved in activation of Notch signaling by AGEs in the pathogenesis of diabetic kidney disease
Baishya, S., Sarangi, A., Somvanshi, P. R., & Pasupulati, A. K. (2026) · PLoS ONE · doi:10.1371/journal.pone.0335768
Bacopa monniera : A Promising Phytotherapeutic Approach in Management of Diabetes‐Related Complications
Bhumika, H. S., Pandareesh, M. D., Narasaraju, T., & Ramadas, D. (2026) · Phytotherapy Research · doi:10.1002/ptr.70293
Anti-inflammatory and Anti-adipogenic Effects of Pediococcus pentosaceus TAP041 Under AGE-Associated Conditions
Lee, C., Jeong, H., & Park, Y. (2026) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-026-11070-2
Pathophysiological mechanisms, potential biomarkers, and therapeutic interventions in diabetic nephropathy
Vyas, K., Chhipa, A. S., Chauhan, A., & Patel, S. S. (2026) · Discover Molecules · doi:10.1007/s44345-026-00071-x
A standardized fraction of Cajanus scarabaeoides attenuates diabetic nephropathy via antiglycation, anti-inflammatory, and anti-fibrotic mechanisms
Baghel, R., Maurya, A. K., Kaushik, P., Yadav, M., Ahmad, I., Mugale, M. N., Kanojiya, S., & Tamrakar, A. K. (2026) · Journal of Natural Medicines · doi:10.1007/s11418-026-02089-4

Authors: Kumar Pasupulati, A., Chitra, P. S., & Reddy, G. B.
Affiliations: Department of Biochemistry, University of Hyderabad, Hyderabad 500 046, India
National Institute of Nutrition (IN)
Corresponding author: Reddy, G. Bhanuprakash
ORCID: Reddy, G. Bhanuprakash
Venue: Biomolecular Concepts
Publisher: Walter de Gruyter GmbH
Published: 2016-11-07
Volume: 7
Issue: 5-6
Pages: 293-309
ISSN: 1868-5021 (ISSN-L)
1868-503X
DOI: 10.1515/bmc-2016-0021
OpenAlex: W2550737605
Cited by: 163
References: 110
Citations by year: 2026: 7 · 2025: 18 · 2024: 19 · 2023: 21 · 2022: 25 · 2021: 29 · 2020: 19 · 2019: 9 · 2018: 8 · 2017: 8
FWCI: 0.86
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-nd
creativecommons.org/licenses/by-nc-nd/3.0/ (unspecified)
Locations: BioMolecular Concepts (publishedVersion, cc-by-nc-nd)
PubMed (publishedVersion)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders: Defence Research and Development Organisation
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
Keywords: diabetic nephropathy, advanced glycation end products, glycation, receptor for advanced glycation end products, renal fibrosis, renin-angiotensin system, proteinuria, glomerulosclerosis, inflammation, apoptosis, autophagy
MeSH terms: Receptor for Advanced Glycation End Products, Diabetic Nephropathies, Humans, Protein Binding, Renin-Angiotensin System, Signal Transduction, Glycation End Products, Advanced, Podocytes, Epithelial-Mesenchymal Transition, Molecular Targeted Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Advanced glycation end products mediated cellular and molecular events in the pathology of diabetic nephropathy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks